Contemporary Concise Review 2023: Advances in lung cancer and interventional pulmonology
Details
Publication Year 2024-08,Volume 29,Issue #8,Page 665-673
Journal Title
Respirology
Publication Type
Review
Abstract
Eligibility criteria for lung cancer screening increasingly need to consider family history of lung cancer, as well as age and smoking status. Lung cancer screening will reveal a multitude of incidental findings, of variable clinical significance, and with a need for clear pathways of management. Pulmonary nodule sampling is enhanced by intra-procedural imaging and cutting-edge robotic technology. Systematic thoracic lymph node sampling has implications for treatment efficacy. Bronchoscopic ablative techniques are feasible for peripheral lung cancers. Bronchoscopic sampling continues to have a high yield for lung cancer molecular characterization. Immunotherapy indications have expanded to include early stage and resectable lung cancer.
Publisher
Wiley
Keywords
Humans; *Lung Neoplasms/pathology/therapy; *Bronchoscopy/methods; *Early Detection of Cancer/methods; *Pulmonary Medicine/methods; Immunotherapy/methods; Nsclc; bronchoscopy; emphysema; immunotherapy; lung cancer
Department(s)
Internal Medicine
Open Access at Publisher's Site
https://doi.org/10.1111/resp.14789
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-08-06 05:29:22
Last Modified: 2024-08-06 05:31:19

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙